Header Logo
Last Name

You can now add alternative names! Click here to add other names that you've published under.


Search Results to Tarun Garg

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Garg, Tarun

research overview My research is focus on developing natural killer (NK) cells for immunotherapeutic use against multiple myeloma, which has poor outcome despite novel therapeutic agents. In addition, elucidation of resistance mechanisms in myeloma is another area of my interest. Myeloma cells has the ability to evade immune surveillance through several potential mechanisms. Exploration of these mechanisms may lead to develop better therapeutic option in multiple myeloma.

One or more keywords matched the following items that are connected to Garg, Tarun

Item TypeName
Academic Article Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2.
Academic Article Generation of recombinant skin in vitro by adeno-associated virus type 2 vector transduction.
Academic Article 15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress.
Academic Article Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma.
Academic Article Highly activated and expanded natural killer cells for multiple myeloma immunotherapy.
Academic Article Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.
Academic Article Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.
Academic Article Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103.
Concept Cells, Cultured
Concept Killer Cells, Natural
Concept Tumor Cells, Cultured
Concept T-Lymphocytes
Concept K562 Cells
Concept T-Lymphocytes, Cytotoxic
Academic Article Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients.
Grant Potentiating Natural Killer Cell Anti-Myeloma Effects
Grant Multiple Myeloma Cells Modulate ICAM-3 to Evade Natural Killer Cell-Mediated Lysis
Grant Multiple Myeloma Cells Modulate ICAM-3 to Evade Natural Killer Cell-Mediated Lysis

Search Criteria
  • B Lymphocytes